Citation Impact
Citing Papers
Obesity, Type 2 Diabetes and Bone in Adults
2017
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
2018 Standout
TRP channels in calcium homeostasis: from hormonal control to structure-function relationship of TRPV5 and TRPV6
2016
Sarcopenia: a chronic complication of type 2 diabetes mellitus
2018 Standout
Cardiac and Renal Effects of Sodium-Glucose Co-Transporter 2 Inhibitors in Diabetes
2018
Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular events, death, and major safety outcomes in adults with type 2 diabetes: a systematic review and meta-analysis
2016
The human milk microbiome and factors influencing its composition and activity
2016
Effects of Sotagliflozin Added to Insulin in Patients with Type 1 Diabetes
2017
Reshaping the gut microbiota: Impact of low calorie sweeteners and the link to insulin resistance?
2016
Diabetic ketosis during hyperglycemic crisis is associated with decreased all-cause mortality in patients with type 2 diabetes mellitus
2016
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
2017 Standout
Role of the gut microbiota in nutrition and health
2018 Standout
La paradoja diabética: densidad mineral ósea y fractura en la diabetes tipo 2
2016
Impact of empagliflozin in patients with diabetes and heart failure
2016
SGLT-2 inhibitors: Their pleiotropic properties
2016
Strategy for Mitigating DKA Risk in Patients with Type 1 Diabetes on Adjunctive Treatment with SGLT Inhibitors: A STICH Protocol
2018
Sodium–Glucose Cotransporter 2 Inhibitors: A Case Study in Translational Research
2019
Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019
2020 Standout
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2018 Standout
Sodium Glucose Cotransporter-2 Inhibition in Heart Failure
2017
Diabetic Cardiomyopathy
2018 Standout
Cardiovascular Safety, Long‐Term Noncardiovascular Safety, and Efficacy of Sodium–Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes Mellitus: A Systemic Review and Meta‐Analysis With Trial Sequential Analysis
2018
Diabetic Kidney Disease
2017 Standout
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
2020 Standout
Sodium Glucose Cotransporter 2 Inhibitors in the Treatment of Diabetes Mellitus
2016
The First Microbial Colonizers of the Human Gut: Composition, Activities, and Health Implications of the Infant Gut Microbiota
2017 Standout
Structural insight into TRPV5 channel function and modulation
2019 StandoutNobel
The diabetic paradox: Bone mineral density and fracture in type 2 diabetes
2016
The effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on mineral metabolism and bone in patients with type 2 diabetes mellitus
2016
Dapagliflozin in patients with type 2 diabetes mellitus: A pooled analysis of safety data from phase IIb/III clinical trials
2017
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
2018 Standout
Works of Jenny E. Blau being referenced
Adverse effects of SGLT2 inhibitors on bone health
2018
The PTH-Vitamin D-FGF23 axis
2015
SGLT2 Inhibitors May Predispose to Ketoacidosis
2015
Possible adverse effects of SGLT2 inhibitors on bone
2014
Canagliflozin triggers the FGF23/1,25-dihydroxyvitamin D/PTH axis in healthy volunteers in a randomized crossover study
2018
Ketoacidosis associated with SGLT2 inhibitor treatment: Analysis of FAERS data
2017
Nonnutritive Sweeteners in Breast Milk
2015